5H25
EED in complex with PRC2 allosteric inhibitor compound 11
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRF BEAMLINE BL17U |
Synchrotron site | SSRF |
Beamline | BL17U |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2013-01-08 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.978524 |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 94.747, 179.379, 50.396 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 43.940 - 2.880 |
R-factor | 0.189 |
Rwork | 0.184 |
R-free | 0.27400 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2qxv |
RMSD bond length | 0.010 |
RMSD bond angle | 1.180 |
Data scaling software | SCALEPACK |
Phasing software | MOLREP |
Refinement software | BUSTER (2.10.2) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 50.000 | 50.000 | 3.000 |
High resolution limit [Å] | 2.880 | 6.240 | 2.880 |
Rmerge | 0.110 | 0.049 | 0.485 |
Total number of observations | 102204 | ||
Number of reflections | 19963 | ||
<I/σ(I)> | 6.9 | ||
Completeness [%] | 99.4 | 97.1 | 99.8 |
Redundancy | 5.1 | 5 | 5.2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 8 | 293 | 0.1 M Tris, 16% PEG 8000, 10 mM beta-Nicotinamide mononucleotide |